Literature DB >> 15341737

An asymmetric complex of restriction endonuclease MspI on its palindromic DNA recognition site.

Qian Steven Xu1, Rebecca B Kucera, Richard J Roberts, Hwai-Chen Guo.   

Abstract

Most well-known restriction endonucleases recognize palindromic DNA sequences and are classified as Type IIP. Due to the recognition and cleavage symmetry, Type IIP enzymes are usually found to act as homodimers in forming 2-fold symmetric enzyme-DNA complexes. Here we report an asymmetric complex of the Type IIP restriction enzyme MspI in complex with its cognate recognition sequence. Unlike any other Type IIP enzyme reported to date, an MspI monomer and not a dimer binds to a palindromic DNA sequence. The enzyme makes specific contacts with all 4 base pairs in the recognition sequence, by six direct and five water-mediated hydrogen bonds and numerous van der Waal contacts. This MspI-DNA structure represents the first example of asymmetric recognition of a palindromic DNA sequence by two different structural motifs in one polypeptide. A few possible pathways are discussed for MspI to cut both strands of DNA, either as a monomer or dimer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341737     DOI: 10.1016/j.str.2004.07.014

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  19 in total

1.  A view of consecutive binding events from structures of tetrameric endonuclease SfiI bound to DNA.

Authors:  Eva Scheuring Vanamee; Hector Viadiu; Rebecca Kucera; Lydia Dorner; Stephen Picone; Ira Schildkraut; Aneel K Aggarwal
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

2.  Two crystal forms of the restriction enzyme MspI-DNA complex show the same novel structure.

Authors:  Qian Steven Xu; Richard J Roberts; Hwai-Chen Guo
Journal:  Protein Sci       Date:  2005-10       Impact factor: 6.725

Review 3.  Type II restriction endonucleases--a historical perspective and more.

Authors:  Alfred Pingoud; Geoffrey G Wilson; Wolfgang Wende
Journal:  Nucleic Acids Res       Date:  2014-05-30       Impact factor: 16.971

4.  Target site cleavage by the monomeric restriction enzyme BcnI requires translocation to a random DNA sequence and a switch in enzyme orientation.

Authors:  Giedrius Sasnauskas; Georgij Kostiuk; Gintautas Tamulaitis; Virginijus Siksnys
Journal:  Nucleic Acids Res       Date:  2011-07-19       Impact factor: 16.971

5.  Structural and evolutionary classification of Type II restriction enzymes based on theoretical and experimental analyses.

Authors:  Jerzy Orlowski; Janusz M Bujnicki
Journal:  Nucleic Acids Res       Date:  2008-05-02       Impact factor: 16.971

6.  BspRI restriction endonuclease: cloning, expression in Escherichia coli and sequential cleavage mechanism.

Authors:  Tamás Raskó; András Dér; Eva Klement; Krystyna Slaska-Kiss; Eszter Pósfai; Katalin F Medzihradszky; Daniel R Marshak; Richard J Roberts; Antal Kiss
Journal:  Nucleic Acids Res       Date:  2010-06-29       Impact factor: 16.971

7.  Crystal structure of a polypeptide's C-terminus in complex with the regulatory domain of ER aminopeptidase 1.

Authors:  Lufei Sui; Amit Gandhi; Hwai-Chen Guo
Journal:  Mol Immunol       Date:  2016-11-05       Impact factor: 4.407

8.  Tetrameric restriction enzymes: expansion to the GIY-YIG nuclease family.

Authors:  Giedrius Gasiunas; Giedrius Sasnauskas; Gintautas Tamulaitis; Claus Urbanke; Dalia Razaniene; Virginijus Siksnys
Journal:  Nucleic Acids Res       Date:  2007-12-17       Impact factor: 16.971

9.  Sequence, structure and functional diversity of PD-(D/E)XK phosphodiesterase superfamily.

Authors:  Kamil Steczkiewicz; Anna Muszewska; Lukasz Knizewski; Leszek Rychlewski; Krzysztof Ginalski
Journal:  Nucleic Acids Res       Date:  2012-05-25       Impact factor: 16.971

10.  Asymmetric DNA recognition by the OkrAI endonuclease, an isoschizomer of BamHI.

Authors:  Eva Scheuring Vanamee; Hector Viadiu; Siu-Hong Chan; Ajay Ummat; Adrian M Hartline; Shuang-yong Xu; Aneel K Aggarwal
Journal:  Nucleic Acids Res       Date:  2010-09-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.